Thus, we hypothesize that IL-6 upregulation in COVID-19, as well as IL-3 and IL-11 upregulation, is likely involved in the stimulation of megakaryocytes and possibly also resident megakaryocytes in the lung. The gene discussed is IL11; the disease is COVID-19.